newsfilter
← Latest News
GlobeNewswire·

Athenex to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

BUFFALO, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today an